Burden of Early Antibody-Mediated Rejection (AMR): Complications, Resource Utilization and Cost-Differential in Treatment of AMR

被引:0
作者
Banga, R. [1 ]
Schinstock, C. [1 ]
Boscoe, A. [4 ]
Hathcock, M. [3 ]
Kremers, W. [3 ]
Stegall, M. [2 ]
机构
[1] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA
[2] Mayo Clin, Div Transplantat Surg, Rochester, MN USA
[3] Mayo Clin, Div Biostat, Rochester, MN USA
[4] Alex Pharmaceut, Hlth Outcomes Res, Cheshire, CT USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
3017
引用
收藏
页数:1
相关论文
共 50 条
[21]   Inflammatory Cell Burden and Phenotype in Endomyocardial Biopsies from Patients with Antibody-Mediated Rejection (AMR) - An AECVP Multicenter Study [J].
Fedrigo, M. ;
Leone, O. ;
Burke, M. ;
Rice, A. ;
Toquet, C. ;
Frigo, A. C. ;
Guillemain, R. ;
Pattier, S. ;
Smith, J. ;
Lota, A. ;
Potena, L. ;
Bontadini, A. ;
Ceccarelli, C. ;
Poli, F. ;
Feltrin, G. ;
Gerosa, G. ;
Manzan, E. ;
Thiene, G. ;
Bruneval, P. ;
Angelini, A. ;
Van Huyen, J. -P. Duong .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04) :S19-S19
[22]   Identification of Histological and Clinical Features Associated with Antibody-Mediated Rejection (AMR) in Liver Allografts [J].
Forse, Catherine ;
Tarokh, Morteza ;
Robertson, Scott ;
Roberts, Daniel ;
Yerian, Lisa ;
Tu, Chao ;
Eghtesad, Bijan ;
Hashimoto, Koji ;
Aucejo, Federico ;
Allende, Daniela .
LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) :1518-1520
[23]   Identification of Histological and Clinical Features Associated with Antibody-Mediated Rejection (AMR) in Liver Allografts [J].
Forse, Catherine ;
Tarokh, Morteza ;
Robertson, Scott ;
Roberts, Daniel ;
Yerian, Lisa ;
Tu, Chao ;
Eghtesad, Bijan ;
Hashimoto, Koji ;
Aucejo, Federico ;
Allende, Daniela .
MODERN PATHOLOGY, 2020, 33 (SUPPL 2) :1518-1520
[24]   Inflammatory Cell Burden and Phenotype in Endomyocardial Biopsies With Antibody-Mediated Rejection (AMR): A Multicenter Pilot Study From the AECVP [J].
Fedrigo, M. ;
Leone, O. ;
Burke, M. M. ;
Rice, A. ;
Toquet, C. ;
Vernerey, D. ;
Frigo, A. -C. ;
Guillemain, R. ;
Pattier, S. ;
Smith, J. ;
Lota, A. ;
Potena, L. ;
Bontadini, A. ;
Ceccarelli, C. ;
Poli, F. ;
Feltrin, G. ;
Gerosa, G. ;
Manzan, E. ;
Thiene, G. ;
Bruneval, P. ;
Angelini, A. ;
Van Huyen, J. -P. Duong .
AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 (02) :526-534
[25]   COMPARISON OF PEDIATRIC PATIENTS WITH PURE ANTIBODY-MEDIATED REJECTION (AMR) AND RECIPIENTS WITH BOTH AMR AND VASCULAR REJECTION IN THE DEVELOPMENT OF INTERSTITIAL FIBROSIS AND TRANSPLANT GLOMERULOPATHY. [J].
Ozdemir, B. Handan ;
Ayva, S. ;
Baskin, E. ;
Ozdemir, F. Nurhan ;
Moray, G. ;
Haberal, M. .
PEDIATRIC TRANSPLANTATION, 2017, 21 :44-44
[26]   Genome-Wide DNA Methylation Analysis to Define Pulmonary Antibody-Mediated Rejection (AMR) Treatment Response [J].
Jang, M. ;
Singh, K. ;
Andargie, T. ;
Seifuddin, F. ;
Tunc, I. ;
Park, W. ;
Lee, J. ;
Kong, H. ;
Agbor-Enoh, S. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04) :S39-S39
[27]   Does Gender Mismatch Increase the Risk of Antibody-Mediated Rejection (AMR) after Heart Transplantation? [J].
Patel, J. ;
Kittleson, M. ;
Kawano, M. ;
Goldstein, Z. ;
Rafiei, M. ;
Barry, O. ;
Hamilton, M. ;
Schwarz, E. ;
Esmailian, F. ;
Kobashigawa, J. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04) :S178-S178
[28]   Antibody-mediated rejection (AMR) in pediatric lung transplantation-Current state and future directions [J].
Benden, Christian ;
Wikenheiser-Brokamp, Kathryn A. .
PEDIATRIC TRANSPLANTATION, 2024, 28 (02)
[29]   EARLY ACUTE ANTIBODY-MEDIATED REJECTION (AMR) AFTER LUNG TRANSPLANTATION SUCCESSFULLY TREATED WITH C5 BLOCKADE [J].
Muller, Yannick ;
Aubert, John-David ;
Vionnet, Julien ;
Rotman, Samuel ;
Aubert, Vincent ;
Pascual, Manuel .
TRANSPLANT INTERNATIONAL, 2017, 30 :543-543
[30]   Use of Bortezomib in the Treatment of Antibody Mediated Rejection (AMR) in Pediatric Heart Recipients [J].
Otero, J. ;
Albers, E. ;
Friedland-Little, J. ;
Hong, B. ;
Kemna, M. ;
Gimferrer, I. ;
Law, Y. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04) :S469-S469